Acute Kidney Injury (AKI) is associated with increased mortality and morbidity in COVID-19 patients.
It is hypothesised to be worse in patients with underlying Chronic Kidney Disease (CKD).
The aetiology of AKI in these patients is multifactorial with direct cytopathic effects on kidney tissue, involvement of angiotensin-converting enzyme 2 and immune mediated coagulopathy being responsible.
Although some studies have shown an association between kidney involvement and poor outcome in COVID-19, information on this subject remains limited.
We evaluated the prevalence of AKI in a subgroup of patients with COVID-19 and the associated mortality.
You can read and download the poster HERE